HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaki Watanabe Selected Research

1- (3,5,5,8,8- pentamethyl- 5,6,7,8- tetrahydro- 2- naphthyl)- 1H- benzotriazole- 5- carboxylic acid

1/2019A partial agonist for retinoid X receptor mitigates experimental colitis.
1/2017Synthesis of 11C-Labeled RXR Partial Agonist 1-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic Acid (CBt-PMN) by Direct [11C]Carbon Dioxide Fixation via Organolithiation of Trialkyltin Precursor and PET Imaging Thereof.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaki Watanabe Research Topics

Disease

7Neoplasms (Cancer)
07/2023 - 06/2003
6Fibrosis (Cirrhosis)
10/2023 - 07/2005
6Stroke (Strokes)
12/2017 - 05/2005
5Colitis
03/2024 - 11/2014
5Inflammation (Inflammations)
02/2023 - 09/2003
5Type 2 Diabetes Mellitus (MODY)
10/2019 - 05/2002
5Pneumonia (Pneumonitis)
12/2015 - 02/2006
5Aneurysm (Aneurysms)
09/2014 - 01/2012
4Lower Urinary Tract Symptoms
10/2020 - 05/2013
4Overactive Urinary Bladder (Overactive Bladder)
01/2018 - 04/2011
4Ischemic Stroke
01/2015 - 05/2005
4Thrombosis (Thrombus)
06/2012 - 04/2006
4Insulin Resistance
01/2010 - 12/2004
3Alzheimer Disease (Alzheimer's Disease)
01/2021 - 08/2002
3Interstitial Lung Diseases (Interstitial Lung Disease)
10/2016 - 09/2015
3Chronic Obstructive Pulmonary Disease (COPD)
12/2015 - 12/2005
3Infections
12/2015 - 06/2010
3Asthma (Bronchial Asthma)
08/2014 - 02/2006
3Churg-Strauss Syndrome (Allergic Angiitis)
09/2008 - 02/2006
3Idiopathic Pulmonary Fibrosis
03/2006 - 05/2005
2Genetic Predisposition to Disease (Genetic Predisposition)
04/2024 - 01/2021
2Chronic Renal Insufficiency
11/2023 - 02/2023
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
09/2022 - 01/2019
2Lung Diseases (Lung Disease)
01/2021 - 05/2005
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/2020 - 05/2013
2Brain Neoplasms (Brain Tumor)
12/2017 - 09/2006
2Connective Tissue Diseases (Connective Tissue Disease)
08/2016 - 09/2015
2Neoplasm Metastasis (Metastasis)
02/2016 - 09/2006
2Atrial Fibrillation
04/2015 - 02/2012
2Rupture
09/2014 - 02/2009
2Interstitial Cystitis (Interstitial Cystitis, Chronic)
02/2013 - 09/2003
2Intracranial Aneurysm (Cerebral Aneurysm)
06/2012 - 03/2011
2Pathologic Constriction (Stenosis)
01/2011 - 05/2005
2Hypertension (High Blood Pressure)
01/2010 - 01/2010
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2008 - 07/2004
2Neutropenia
10/2008 - 07/2004
2Urinary Tract Infections (Urinary Tract Infection)
05/2008 - 10/2006
2Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2007 - 02/2006
2Systemic Vasculitis
10/2006 - 02/2006
2Macular Edema
08/2005 - 09/2004
2Diabetic Retinopathy (Retinopathy, Diabetic)
09/2004 - 05/2002
1Unconsciousness (Loss of Consciousness)
03/2024
1Pain (Aches)
03/2024
1Colorectal Neoplasms (Colorectal Cancer)
03/2024
1Carcinogenesis
03/2024
1Tauopathies
12/2023
1TDP-43 Proteinopathies
12/2023
1Proteostasis Deficiencies
12/2023
1Ureteral Obstruction
10/2023
1Hyperplasia
10/2023
1T-Cell Lymphoma (Lymphoma, T Cell)
03/2023
1Calculi (Calculus)
12/2022

Drug/Important Bio-Agent (IBA)

9Retinoid X Receptors (Retinoid X Receptor)IBA
09/2022 - 01/2017
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009 - 05/2002
6Discoidin Domain Receptor 1IBA
11/2008 - 05/2005
5Proteins (Proteins, Gene)FDA Link
03/2024 - 06/2009
5Bleomycin (Blenoxane)FDA LinkGeneric
10/2016 - 07/2005
4Doxorubicin (Adriamycin)FDA LinkGeneric
04/2024 - 02/2023
4Bexarotene (LGD1069)FDA Link
03/2023 - 01/2017
4CytokinesIBA
02/2023 - 12/2005
4Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 10/2010
3ChemokinesIBA
12/2015 - 05/2005
3PPAR gammaIBA
01/2010 - 12/2004
3Member 10c Tumor Necrosis Factor ReceptorsIBA
09/2008 - 07/2004
2Dextrans (Dextran)FDA Link
03/2024 - 01/2019
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
03/2024 - 01/2019
2LigandsIBA
12/2023 - 10/2019
2salicylhydroxamic acid (SHAM)IBA
10/2023 - 02/2013
2Adrenergic Receptors (Adrenergic Receptor)IBA
10/2020 - 05/2013
2naftopidilIBA
10/2020 - 05/2013
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 12/2004
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2019 - 12/2005
21- (3,5,5,8,8- pentamethyl- 5,6,7,8- tetrahydro- 2- naphthyl)- 1H- benzotriazole- 5- carboxylic acidIBA
01/2019 - 01/2017
2Muscarinic AntagonistsIBA
01/2018 - 05/2016
2B-Cell Activating FactorIBA
08/2016 - 09/2015
2Immunoglobulins (Immunoglobulin)IBA
02/2016 - 07/2005
2LeukotrienesIBA
12/2015 - 05/2006
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2015 - 05/2006
2SiliconesIBA
09/2014 - 06/2012
2Cilostazol (Pletal)FDA LinkGeneric
03/2014 - 01/2011
2AdiponectinIBA
01/2010 - 12/2004
2Immunoglobulin G (IgG)IBA
09/2009 - 03/2008
2Bevacizumab (Avastin)FDA Link
06/2009 - 03/2008
2plerixaforFDA Link
11/2008 - 05/2007
2TNF-Related Apoptosis-Inducing LigandIBA
10/2008 - 07/2004
2CollagenIBA
03/2006 - 05/2005
2glimepiride (Amarel)FDA LinkGeneric
06/2005 - 03/2005
1AzoxymethaneIBA
03/2024
1DNA-Binding Proteins (DNA Binding Protein)IBA
12/2023
1Calcium OxalateIBA
10/2023
1OxalatesIBA
10/2023
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
03/2023
1Dextran SulfateIBA
02/2023
1Diamino Amino AcidsIBA
12/2022

Therapy/Procedure

23Therapeutics
10/2020 - 09/2003
5Stents
04/2015 - 05/2005
3Drug Therapy (Chemotherapy)
07/2023 - 09/2006
2Aftercare (After-Treatment)
09/2022 - 06/2010
2Cranial Irradiation
12/2017 - 01/2015
1Euthanasia (Mercy Killing)
03/2024